NuVasive Cohere ALIF System Intervertebral Body Fusion Device
K-Number: K221751 · 2022-10-21
ApplicantNu Vasive, Incorporated
Decision Date2022-10-21
Product CodeOVD
Advisory CommitteeOR
DecisionSubstantially Equivalent
Device Summary
NuVasive Cohere ALIF System Intervertebral Body Fusion Device is a medical device manufactured by Nu Vasive, Incorporated. It received FDA 510(k) clearance on 2022-10-21 under approval number K221751. The device is classified under product code OVD. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the NuVasive Cohere ALIF System Intervertebral Body Fusion Device?
NuVasive Cohere ALIF System Intervertebral Body Fusion Device is a medical device that received FDA 510(k) clearance on 2022-10-21. It is manufactured by Nu Vasive, Incorporated. The 510(k) number is K221751.
When was NuVasive Cohere ALIF System Intervertebral Body Fusion Device approved by the FDA?
NuVasive Cohere ALIF System Intervertebral Body Fusion Device received FDA 510(k) clearance on 2022-10-21, under approval number K221751.
What company makes NuVasive Cohere ALIF System Intervertebral Body Fusion Device?
NuVasive Cohere ALIF System Intervertebral Body Fusion Device is manufactured by Nu Vasive, Incorporated.
What is the FDA product code for NuVasive Cohere ALIF System Intervertebral Body Fusion Device?
The FDA product code for NuVasive Cohere ALIF System Intervertebral Body Fusion Device is OVD.
Related Clinical Trials
NCT06998134
Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults
RECRUITING
NCT07301385
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
ACTIVE_NOT_RECRUITING
NCT07296744
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
RECRUITING
NCT07222787
Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes
RECRUITING
NCT03262415
PRECISION Study: Evaluating the Accuracy of the LabPatch Continuous Glucose Monitor
COMPLETED
NCT07611721
Evaluate the Performance of the Dexcom G7 Continuous Glucose Monitoring (CGM) System in Critically Ill Patients Undergoing Major Abdominal Surgery and Solid Organ Transplantation Which Require Blood Glucose Monitoring for Intensive Insulin Therapy.
RECRUITING
Related PubMed Literature
PMID: 42201559
Time-series and thematic analyses of clinical utilities and operational issues in early clinical studies of the da Vinci surgical system.
Journal of robotic surgery (2026)
PMID: 41879133
Medical Device Regulation - Who Does the FDA Serve?
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics (2026)
PMID: 41839575
A Perspective for Integrating Real-World Evidence Into the Investigational Device Exemption Study Design for Lumbar Total Joint Replacement.
International journal of spine surgery (2026)
PMID: 40775988
B-onic Suite: An Integrated Platform for Personalized Medical Devices, Real-Time Surgical Planning, and Enhanced Intraoperative Navigation.
Studies in health technology and informatics (2025)
Other Devices by Nu Vasive, Incorporated
Related Devices (Code: OVD)
K162680SOVEREIGN® Spinal SystemMedtronic Sofamor Danek USA, Inc.
K162351SeaSpine® Vu aPOD Prime NanoMetalene® Intervertebral Body Fusion DeviceSeaSpine Orthopedics Corporation
K161993Leva® Anterior Interbody SystemSpine Wave, Inc.
K161379ELSA SpacersGlobus Medical, Inc.
K161173Avenue® T TLIF CageLdr Spine USA, Inc.
K161129PILLAR SA PTCOrthofix, Inc.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.